Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764159
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of WarsawNot Yet RecruitingNot Applicable
NCT07764159Not Yet Recruiting
Not Applicable
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of War...
NCT07762105
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye DiseaseBanu Aji DibyasaktiNot Yet RecruitingPhase 1
NCT07762105Not Yet Recruiting
Phase 1
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Pa...Banu Aji Dibyasakti
NCT07763665
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein ComplexAssiut UniversityNot Yet RecruitingPhase 4
NCT07763665Not Yet Recruiting
Phase 4
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Inju...Assiut University
NCT07761962
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible PulpitisKing Abdullah University HospitalActive Not RecruitingNot Applicable
NCT07761962Active Not Recruiting
Not Applicable
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversib...King Abdullah University...
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
NCT07763327
Effects of a Wearable Device ,Phone App and Exercise on Cervico-thoracic Posture in University Students.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07763327Not Yet Recruiting
Not Applicable
Effects of a Wearable Device ,Phone App and Exercise on Cervico-thoracic Posture...Riphah International Univ...
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762976
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaFudan UniversityRecruitingPhase 2
NCT07762976Recruiting
Phase 2
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasoph...Fudan University
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07763626
Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLDUniversity of GenovaCompletedNot Applicable
NCT07763626Completed
Not Applicable
Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLDUniversity of Genova
NCT07763964
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763964Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763717
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIALAlma Mater Europaea - SloveniaNot Yet RecruitingNot Applicable
NCT07763717Not Yet Recruiting
Not Applicable
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE...Alma Mater Europaea - Slo...
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
NCT07763119
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration SyndromeKhyber Teaching HospitalCompletedPhase 3
NCT07763119Completed
Phase 3
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration...Khyber Teaching Hospital
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07762924
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryFudan UniversityRecruitingPhase 2
NCT07762924Recruiting
Phase 2
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Fol...Fudan University
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed4 (20%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 13 (15%)
Phase 33 (15%)
Phase 23 (15%)
Phase 41 (5%)
Not Specified1 (5%)